Skip to main content

ADVERTISEMENT

Embolic Protection

Brain Health for Cardiology
03/05/2017
The TAVR procedure risks relate to embolic material that is dislodged during the procedure, and for the brain, that really is the greatest risk of the procedure. The embolic material can lead to stroke and infarction in the brain.   
The TAVR procedure risks relate to embolic material that is dislodged during the procedure, and for the brain, that really is the greatest risk of the procedure. The embolic material can lead to stroke and infarction in the brain.   
The TAVR procedure risks relate...
03/05/2017
Cath Lab Digest
Calcium Corner
01/10/2017
We as physicians should be very interested in the promise of a device like Sentinel that is showing potential in reducing brain lesions in TAVR. 
We as physicians should be very interested in the promise of a device like Sentinel that is showing potential in reducing brain lesions in TAVR. 
We as physicians should be very...
01/10/2017
Cath Lab Digest
04/04/2013
We present a case of a lesion within a previously placed right coronary artery stent that was determined to be thrombotic in nature, thereby guiding the strategy for percutaneous coronary intervention.
We present a case of a lesion within a previously placed right coronary artery stent that was determined to be thrombotic in nature, thereby guiding the strategy for percutaneous coronary intervention.
We present a case of a lesion...
04/04/2013
Cath Lab Digest
06/19/2008
Two carotid artery stent systems consisting of a self-expanding stent and compatible embolic protection filter device have marketing clearance by the United States Food and Drug Administration (FDA). The Guidant Corporation Acculink® Carotid...
Two carotid artery stent systems consisting of a self-expanding stent and compatible embolic protection filter device have marketing clearance by the United States Food and Drug Administration (FDA). The Guidant Corporation Acculink® Carotid...
Two carotid artery stent systems...
06/19/2008
Cath Lab Digest
Feature
06/19/2008
Two carotid artery stent systems consisting of a self-expanding stent and compatible embolic protection filter device have marketing clearance by the United States Food and Drug Administration (FDA). The Guidant Corporation Acculink® Carotid...
Two carotid artery stent systems consisting of a self-expanding stent and compatible embolic protection filter device have marketing clearance by the United States Food and Drug Administration (FDA). The Guidant Corporation Acculink® Carotid...
Two carotid artery stent systems...
06/19/2008
Cath Lab Digest
06/19/2008
What are the latest developments in carotid stenting trials and research? In July of this year, Kensey Nash Corporation announced a Board of Directors decision to cease all activities involving the marketing and regulatory approval process...
What are the latest developments in carotid stenting trials and research? In July of this year, Kensey Nash Corporation announced a Board of Directors decision to cease all activities involving the marketing and regulatory approval process...
What are the latest developments...
06/19/2008
Cath Lab Digest
Feature
06/19/2008
What are the latest developments in carotid stenting trials and research? In July of this year, Kensey Nash Corporation announced a Board of Directors decision to cease all activities involving the marketing and regulatory approval process...
What are the latest developments in carotid stenting trials and research? In July of this year, Kensey Nash Corporation announced a Board of Directors decision to cease all activities involving the marketing and regulatory approval process...
What are the latest developments...
06/19/2008
Cath Lab Digest